Supriya Lifesci.

SUPRIYA03 May 2024

Pharmaceuticals

₹

-8.60 (-2.05%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Supriya Lifesci.

Supriya Lifesci.

Pharmaceuticals

SUPRIYA03 May 2024

₹

-8.60 (-2.05%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
26-May-2023	D	Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023, recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting. Please find attached herewith Newspaper Publication. (As Per BSE Announcement Dated on 04/09/2023)	15-Sep-2023
20-May-2022	D	The Board at its Meeting held today recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.	01-Sep-2022
27-Feb-2024	BC	Shivani Satish Wagh	26-Feb-2024
27-Feb-2024	BC	Saloni Satish Wagh	26-Feb-2024
30-Jan-2024	BC	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the Unaudited Financial Results for the	07-Feb-2024
27-Oct-2023	BC	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Unaudited Financial Results for the	07-Nov-2023
04-Sep-2023	BC	Please find attached herewith Newspaper Publication. Please find enclosed herewith Proceeding of 15th AGM. (As Per BSE Announcement dated on 29.09.2023)	29-Sep-2023

No Rights has been declared by SUPRIYA

Book Closure

Record Date	Split Date	Purpose
26-Feb-2024	-	Shivani Satish Wagh
26-Feb-2024	-	Saloni Satish Wagh
07-Feb-2024	-	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the Unaudited Financial Results for the
07-Nov-2023	-	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Unaudited Financial Results for the
29-Sep-2023	-	Please find attached herewith Newspaper Publication. Please find enclosed herewith Proceeding of 15th AGM. (As Per BSE Announcement dated on 29.09.2023)

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Supriya Lifescience Ltd ₹410.15(-8.60/-2.05%)	410.15	-8.60	3,301.00	88.58	27.42	4.38
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	67.79	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	67.42	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.95	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	29.81	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	18.89	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	140.07	140.10	132.02	142.27	105.14	112.17
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	140.07	140.10	132.02	142.27	105.14	112.17
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	3.07	2.47	2.92	1.96	2.56	2.61
Total Income	143.14	142.56	134.94	144.23	107.70	114.78
Total Expenditure	98.59	108.34	87.79	87.22	91.10	83.61
PBIDT	44.55	34.22	47.15	57.01	16.61	31.17
Interest	0.49	0.46	0.56	0.71	1.01	0.78
PBDT	44.06	33.76	46.59	56.30	15.59	30.39
Depreciation	3.96	3.98	3.96	3.01	2.95	2.97
Tax	9.66	8.54	9.96	13.21	2.42	10.47
Deferred Tax	0.66	-2.64	4.16	1.85	0.70	0.09
Reported Profit After Tax	29.79	23.88	28.51	38.23	9.52	16.86
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	29.79	23.88	28.51	38.23	9.52	16.86

EPS (Unit Curr.)	3.70	2.97	3.54	4.75	1.18	2.10
EPS (Adj) (Unit Curr.)	3.70	2.97	3.54	4.75	1.18	2.10
Calculated EPS (Unit Curr.)	3.70	2.97	3.54	4.75	1.18	2.10
Calculated EPS (Adj) (Unit Curr.)	3.70	2.97	3.54	4.75	1.18	2.10
Calculated EPS (Ann.) (Unit Curr.)	14.80	11.87	14.17	19.00	4.73	8.38
Calculated EPS (Adj) (Ann.) (Unit Curr.)	14.80	11.87	14.17	19.00	4.73	8.38
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	16.10	16.10	16.10	16.10	16.10	16.10
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	31.81	24.43	35.71	40.07	15.80	27.79
PBDTM(%)	31.46	24.10	35.29	39.57	14.83	27.09
PATM(%)	21.27	17.04	21.60	26.87	9.05	15.03

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	16.10	16.10	14.64	14.64	14.64	14.64
Reserves Total	683.36	599.59	253.95	134.43	79.15	40.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	699.46	615.69	268.59	149.07	93.79	54.66
Secured Loans	16.63	21.30	66.38	78.12	88.35	129.02
Unsecured Loans	5.84	6.12	5.81	4.09	1.49	1.35
Total Debt	22.47	27.42	72.19	82.21	89.84	130.37
Total Liabilities	721.93	643.11	340.78	231.28	183.63	185.03
APPLICATION OF FUNDS :
Gross Block	306.49	222.92	123.06	114.84	94.54	95.58
Less : Accumulated Depreciation	44.95	33.14	23.02	16.26	9.86	4.57
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	261.54	189.78	100.04	98.58	84.68	91.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	67.63	43.41	78.79	40.21	35.35	34.38
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	25.30	0.05	0.05	0.05	0.05	0.12
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	115.77	92.31	72.48	49.46	30.73	31.70
Sundry Debtors	84.66	115.18	73.50	51.63	59.95	53.40
Cash and Bank	157.58	227.91	89.28	74.71	1.73	2.74
Loans and Advances	106.87	62.14	30.21	19.81	40.25	31.74
Total Current Assets	464.89	497.54	265.47	195.61	132.66	119.57
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	77.97	77.17	74.99	74.08	47.87	47.27
Provisions	0.84	0.41	0.91	1.49	5.33	3.56
Total Current Liabilities	78.81	77.58	75.89	75.57	53.21	50.83
Net Current Assets	386.08	419.95	189.57	120.04	79.46	68.74
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	3.17	2.40	0.29	0.00	0.62	0.39
Deferred Tax Liability	16.84	13.54	8.30	7.36	10.31	9.34
Net Deferred Tax	-13.67	-11.14	-8.01	-7.36	-9.69	-8.95
Total Assets	726.88	642.04	360.44	251.52	189.86	185.29
Contingent Liabilities	5.62	5.62	1.57	0.00	0.54	0.54

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	227.91	89.28	74.71	12.40	8.61
Net Cash from Operating Activities	66.19	48.80	75.89	116.67	48.88
Net Cash Used In Investing Activities	-133.15	-59.82	-46.80	-25.14	4.83
Net Cash Used In Financing Activities	-3.37	149.65	-14.52	-29.23	-49.93
Net Inc./Dec In Cash And Cash Equivalents	-70.33	138.63	14.57	62.31	3.79
Cash And Cash Equivalents At End Of The Year	157.58	227.91	89.28	74.71	12.40

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.30%

FII Shareholding

5.36%

DII Shareholding

5.30%

Public Shareholding

21.04%

**Promoter pledged shareholding 68.30%

About Supriya Lifescience Ltd

Supriya Lifescience Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3301 crores. It has reported a sales of Rs. 140.07 crores and a net profit of Rs. 29.79 crores for the quarter ended December 2018. The company management includes Satish Waman Wagh, Satish Waman Wagh,Smita Satish Wagh,Soloni Satish Wagh,Shivani Satish Wagh,Balasahab Gulabrao Sawant,Kedar Shankar Karmarkar,Bhairav Manojbhai Chokshi,Dileep Kumar Jain,Dinesh N Modi,Neelam Yashpal Arora,Shweta Shivdhari Singh,Manoj Deo Dorlikar (Supriya Lifescience Ltd) among others.

Chairman

Satish Waman Wagh

Registered office

207/208 Udyog Bhavan,Sonawala Road Goregaon (East),Mumbai,Maharashtra,400063

FAX :

Background

Incorporation Year2008

Face Value₹2

Market Lot1

How to buy Supriya Lifesci. shares on nse?

To buy Supriya Lifesci. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Supriya Lifesci. share price today?

The Supriya Lifesci. shares price on nse is Rs.410.15 today.

What is the market cap of Supriya Lifesci. shares on BSE ?

The company has a market capitalization of Rs.3301.00Cr

What is the PE & PB ratio of Supriya Lifesci. shares ?

PE is 27.42 and PB is 4.38

What is the 52 Week High and Low of Supriya Lifesci. shares?

Supriya Lifesci. stock price high: Rs.423.5 Supriya Lifesci. stock price low: Rs.214.45